This year has seen more than its share of wildly successful investments, largely playing off of the pandemic — led by biotechnology stocks trying to treat, fight or prevent COVID-19 infections, and the (mostly technology) stocks that rode the accelerating adoption of remote work and play in the wake of “stay at home” and “social […]
Articles
Every year, I scroll through the last twelve months or so of teaser picks and look for one that really stands out as the stinker of the bunch, to be called the Turkey of the Year and hold that place of honor at Thanksgiving time. Hopefully, we can all give thanks that we didn’t own […]
Louis Navellier has been around for far longer than most of the newsletter pundits, and his quantitative system has proven itself to be pretty good on average for long periods of time (though it also has taken big hits during rapid market collapses, of course) — we write about his teaser picks from time to […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
No comments.